Miho Senda

Methylglyoxal Is a Predictor in Type 2 Diabetic Patients of Intima-Media Thickening and Elevation of Blood Pressure

Susumu Ogawa, Keisuke Nakayama, Masaaki Nakayama et al. · Hypertension · 2010 · 108 citations · Full text

Hypertension, Blood Pressure, Metabolic Syndrome +16

Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, Decreases Systolic Blood Pressure in Japanese Hypertensive Patients with Type 2 Diabetes

Susumu Ogawa, Mikihito Ishiki, Kazuhiro Nako et al. · The Tohoku Journal of Experimental Medicine · 2011 · 105 citations · Full text

Hypertension, Pharmacotherapy, Blood Pressure +16

The impact of visceral fat in nonalcoholic fatty liver disease: cross-sectional and longitudinal studies

Masahiko Koda, Manri Kawakami, Yoshikazu Murawaki et al. · Journal of Gastroenterology · 2007 · 87 citations

Obesity, Metabolic Syndrome, Longitudinal Studies +12

The glucagon-like peptide-1 analog liraglutide suppresses ghrelin and controls diabetes in a patient with Prader-Willi syndrome

Miho Senda, Susumu Ogawa, Kazuhiro Nako et al. · Endocrine Journal · 2012 · 71 citations · Full text

Sonographic subcutaneous and visceral fat indices represent the distribution of body fat volume

Masahiko Koda, Miho Senda, Masayuki Kamba et al. · Abdominal Imaging · 2006 · 64 citations

Obesity, Body Composition, Body Fat Volume +9